IN's Walkaide for drop foot:
This article was originally published in Clinica
Innovative Neurotronics, a wholly-owned subsidiary of Hanger Orthopedic Group, has CE-marked for sale in Europe its Walkaide neuromuscular stimulation device for treating drop foot, a condition caused by weakness or paralysis of the muscles involved in lifting the front part of the foot. The Bethesda, Maryland firm said was currently in negotiations with a number of distributors regarding the product's sale in Europe. In the US, Walkaide was sanctioned by the FDA in September 2005, and subsequently launched on May 1 2006
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.